Bio-pharma giant to create 200 jobs in Dundalk

24 Feb 2010

Global pharma player Warner Chilcott is to create 200 new high-skilled jobs at a multi-service campus in Dundalk that will host executive offices, analytical services, manufacturing operations and shared services.

Warner Chilcott, a global speciality pharmaceutical company, currently focuses on the gastroenterology, women’s healthcare, dermatology and urology segments of the US and Western European pharmaceuticals markets.

“We are excited to establish a new headquarters in Dundalk and are delighted with the support being provided by IDA Ireland,” said Roger Boissonneault, Warner Chilcott’s president and chief executive officer.

“We anticipate that the new facility will play an integral role in the growth of our business,” Boissonneault said.

Since being spun out of Warner-Lambert in 1996, Warner Chilcott has evolved through a series of acquisitions and divestitures from a small seller of undifferentiated products to a fully integrated pharmaceutical company with a broad portfolio of leading branded products.

“This development is excellent news for the northeast region and Ireland as a whole,” said Tánaiste and Minister for Enterprise, Trade and Employment, Mary Coughlan TD.

“Dundalk is one of Ireland’s busiest economic corridors, between Dublin and Belfast, and today’s announcement will bring new high-quality employment opportunities to the region, adding further to the region’s portfolio of world-class foreign direct investment companies operating here, which include Xerox, Heinz, Moffett, Diageo, ABB, National Pen and Satir,” Coughlan said.

By John Kennedy

Photo: Global pharma player Warner Chilcott is establishing new headquarters in Dundalk, which may result in 200 new jobs

John Kennedy is a journalist who served as editor of Silicon Republic for 17 years